Meds for adhd and anxiety
Pro Research Analysisby 
Searched over 200M research papers
Medications for ADHD and Anxiety: A Comprehensive Overview
Introduction to ADHD and Anxiety Comorbidity
Attention-deficit/hyperactivity disorder (ADHD) often coexists with anxiety disorders, complicating treatment strategies. Approximately 25% to 35% of children with ADHD also suffer from anxiety disorders, necessitating a nuanced approach to pharmacotherapy . This article synthesizes current research on the efficacy and safety of various medications used to treat ADHD and comorbid anxiety.
Stimulant Medications: Methylphenidate and Amphetamines
Methylphenidate for ADHD and Anxiety
Methylphenidate is a commonly prescribed stimulant for ADHD. Research indicates that children with ADHD and comorbid anxiety respond well to methylphenidate, with an 81% improvement rate in ADHD symptoms . However, the addition of fluvoxamine (an SSRI) to methylphenidate did not show significant benefits for anxiety symptoms compared to a placebo . Another study found that a single dose of methylphenidate did not significantly alter state anxiety levels in children, although there was a potential delayed anxiety-provoking effect .
Amphetamines for ADHD and Anxiety
Amphetamines, including dexamphetamine, lisdexamfetamine, and mixed amphetamine salts, are also used to treat ADHD. These medications have been shown to reduce ADHD symptoms effectively. However, they are associated with higher attrition rates due to adverse events, including emotional lability and anxiety . Despite these concerns, a meta-analysis suggests that psychostimulants, including amphetamines, may actually reduce the risk of anxiety in children with ADHD compared to placebo .
Non-Stimulant Medications: Atomoxetine and Bupropion
Atomoxetine for ADHD and Anxiety
Atomoxetine, a non-stimulant medication, has shown promise in treating both ADHD and comorbid anxiety. Studies indicate that atomoxetine significantly improves ADHD symptoms and reduces anxiety symptoms in children and adolescents Geller2007Kratochvil2005Griffiths2018. In a controlled trial, atomoxetine improved cognitive functions related to ADHD and anxiety, such as response inhibition and fear identification, further supporting its use in comorbid conditions .
Bupropion for ADHD and Anxiety
Bupropion, a dopamine and norepinephrine reuptake inhibitor, is another non-stimulant option. Clinical trials have demonstrated its efficacy in improving ADHD symptoms, with comparable results to methylphenidate . Bupropion is particularly beneficial for patients who do not respond well to stimulants or have comorbid mood disorders, although more extensive research is needed to confirm these findings .
Alternative Treatments: Polyunsaturated Fatty Acids (PUFA)
Polyunsaturated fatty acids (PUFA) have been explored as a treatment for ADHD due to their potential benefits on cognitive and behavioral functions. However, high-certainty evidence suggests that PUFA supplementation does not significantly improve ADHD symptoms compared to placebo . Therefore, while PUFA may offer some benefits, they are not a primary treatment option for ADHD with comorbid anxiety.
Conclusion
Treating ADHD with comorbid anxiety requires a careful selection of medications. Stimulants like methylphenidate and amphetamines are effective for ADHD but have mixed results regarding anxiety. Non-stimulant medications such as atomoxetine and bupropion offer promising alternatives, particularly for patients with anxiety. While PUFA supplementation is not significantly effective, it may still be considered as an adjunct therapy. Clinicians must weigh the benefits and risks of each medication to tailor treatment plans to individual patient needs.
Sources and full results
Most relevant research papers on this topic